We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results:1-10 of 210

Premature development causes unease in China
  • Shook Hardy & Bacon LLP
  • USA, China
  • August 20 2010

Chinese health experts have reportedly estimated that "at least 30,000 children developed early maturity" in Shanghai alone, raising concerns about food additives and pesticides allegedly laden with sex hormones.

Chinese regulations on medical device advertisements
  • Reed Smith LLP
  • China
  • September 21 2009

Effective May 20, 2009, China’s State Administration of Industry and Commerce ("SAIC"), the Ministry of Health (MOH), and the State Food & Drug Administration ("SFDA") jointly issued "Measures for the Examination of Medical Device Advertisements" ("Measures") and "Standards for the Examination and Release of Medical Device Advertisements" ("Standards"), both of which are relevant to medical device manufacturers and distributors advertising medical devices and diagnostic products within China.

Notice to strengthen the administration of the insert sheet and labeling of non-prescription drugs
  • Hogan Lovells
  • China
  • February 26 2007

The State Food and Drug Administration (SFDA) announced on November 30, 2006, a clarification on the application of the standard non-prescription drug insert sheet and labeling over both the non-prescription drug by the State listing (which means the drug is on the non-prescription drug list prepared by the State) and those by registration (which means the drug is registered as nonprescription by the pharmaceutical manufacturer).